Takeda Pharmaceutical Li... (TAK)
NYSE: TAK
· Real-Time Price · USD
14.80
0.03 (0.20%)
At close: Aug 14, 2025, 3:59 PM
15.10
1.99%
Pre-market: Aug 15, 2025, 04:21 AM EDT
0.20% (1D)
| Bid | 13.3 |
| Market Cap | 46.76B |
| Revenue (ttm) | 4,581.6B |
| Net Income (ttm) | 107.88B |
| EPS (ttm) | 0.29 |
| PE Ratio (ttm) | 51.05 |
| Forward PE | 0.33 |
| Analyst | n/a |
| Ask | 16.9 |
| Volume | 1,991,410 |
| Avg. Volume (20D) | 3,264,490 |
| Open | 14.69 |
| Previous Close | 14.77 |
| Day's Range | 14.69 - 14.82 |
| 52-Week Range | 12.80 - 15.53 |
| Beta | 0.27 |
Next Earnings Release
Takeda Pharmaceutical Limited is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-5.25%
Takeda Pharmaceutical shares are trading lower fol...
Unlock content with
Pro Subscription
5 months ago
+2.98%
Takeda Pharmaceutical shares are trading higher after the company announced topline results from phase 3 verify study of rusfertide in patients with polycythemia vera.
